11 months ago
Congratulations to our new PhD, Amelia McCue!
Amelia McCue successfully defended her PhD thesis titled “Engineering Tumor-Selective T Cell Engager Prodrugs for Cancer Immunotherapy” on Thursday May 23, 2024, under the guidance of Dr. Brian Kuhlman.